Chiome Bioscience Inc. designs, develops, and sells monoclonal antibody products for medicine, diagnosis, testing, and life sciences researches. The Company offers research tools and examination material, including diagnostic kits and ethical drugs.

Announcement Of Paper Publication On Cba-1205 Non-Clinical Data

Extension Of The Master Services Agreement With Chugai Pharmaceutical Co., Ltd.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Chiome Bioscience (4583 JP)

Announcement Of Paper Publication On Cba-1205 Non-Clinical Data

Extension Of The Master Services Agreement With Chugai Pharmaceutical Co., Ltd.

[Revised] Chiome Announces Exclusive Licensing Agreement For Anti-Cx3cr1 Antibody

Chiome Announces Exclusive Licensing Agreement For Anti-Cx3cr1 Antibody

Supplementary Information For Financial Results Q3 Fy12/24

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)